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There is a growing recognition of the role the gastrointestinal microbiota plays in
health and disease. Ingested antimicrobial proteins and peptides have the potential to
alter the gastrointestinal microbiota; particularly if protected from digestion. Nisin is an
antimicrobial peptide that is used as a food preservative. This study examined the ability
of nisin to affect the murine microbiota when fed to mice in two different starch based
matrices; a starch dough comprising raw starch granules and a starch gel comprising
starch that was gelatinized and retrograded. The effects of the two starch matrices by
themselves on the microbiota were also examined. Following 16S rRNA compositional
sequencing, beta diversity analysis highlighted a significant difference (p= 0.001, n= 10)
in the murine microbiota between the four diet groups. The differences between the two
nisin containing diets were mainly attributable to differences in the nisin release from
the starch matrices while the differences between the carriers were mainly attributable
to the type of resistant starch they possessed. Indeed, the differences in the relative
abundance of several genera in the mice consuming the starch dough and starch gel
diets, in particular Akkermansia, the relative abundance of which was 0.5 and 11.9%,
respectively (p = 0.0002, n = 10), points to the potential value of resistance starch
as a modulator of beneficial gut microbes. Intact nisin and nisin digestion products (in
particular nisin fragment 22–31) were detected in the feces and the nisin was biologically
active. However, despite a three-fold greater consumption of nisin in the group fed the
nisin in starch dough diet, twice as much nisin was detected in the feces of the group
which consumed the nisin in starch gel diet. In addition, the relative abundance of three
times asmany genera from the lower gastrointestinal tract (GIT) were significantly different
(p < 0.001, n = 10) to the control for the group fed the nisin in starch gel diet, implying
that the starch gel afforded a degree of protection from digestion to the nisin entrapped
within it.
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INTRODUCTION
The gastrointestinal microbiota impacts on the health of the host
in variety of ways, including through its potential to protect
against infection, provide nutrients, and influence on bodyweight
(Clarke et al., 2012; Nicholson et al., 2012; Jandhyala et al., 2015).
The composition of the microbiota, and thus its health effects,
can be altered by a variety of means, including antimicrobials and
diet (Martínez et al., 2010; Cotter et al., 2012; Chung et al., 2016).
Nisin is an antimicrobial peptide with broad activity against
Gram positive bacteria produced by strains of Lactococcus
lactis subsp. lactis (Abee and Delves-Broughton, 2003). Nisin
has been approved for use as a food preservative by both
US Food and Drug Administration, (FDA) (US Food and
Drug Administration, 1988) and by the European Food Safety
Authority (EFSA) with its assigned E number being E 234
(Younes et al., 2017).
Nisin is very stable at low pH and at pH 3 there is <5% loss
of activity when heated to 115◦C for 20min (Davies et al., 1998).
However, while relatively resistant to passage through the acidic
conditions in the stomach, nisin can be digested by pancreatin in
the small intestine (Heinemann andWilliams, 1966; Gough et al.,
2017b), primarily by its trypsin and chymotrypsin components
and thereforemay not reach the lower gastrointestinal tract (GIT)
in an intact form (Jarvis and Mahoney, 1969; Chan et al., 1996).
Few in vivo studies (Table 1) have investigated how dietary
supplementation with nisin affects the microbiota of the lower
GIT (Bernbom et al., 2006; Józefiak et al., 2013; Lauková
et al., 2014; Kieronczyk et al., 2016) and no previous in vivo
study has employed a high throughput sequencing (HTS)-
based approach to examine the impact of nisin on the entire
microbiota. Nisin has been consumed in vivo at up to 239mg
per kg body weight per day without any adverse effects on
food consumption, body weight, hematology, ophthalmology, or
gross pathology (Hagiwara et al., 2010). Although nisin doses of
up to 173.9mg per kg body weigh per day had no impact on
the microbiota in a study on rats (Bernbom et al., 2006), nisin
has been seen to influence the microbiota in some way in the
majority of in vivo studies including those on mice, chickens
and rabbits and in in vitro bovine and human microbiota studies
(Table 1). However, the variation in methods used, and the
previous absence of detailed HTS-based investigations, make
direct comparisons difficult (Table 1).
Starch is the primary carbohydrate source in the adult western
diet (Sibley, 2004). Starch is comprised of the carbohydrate
polymers amylose and amylopectin, and in plants these are
arranged into semi-crystalline starch granules, which are of 0.1–
200µm in diameter. When “raw” starch granules are suspended
in water and heated, the amylose, and amylopectin disassociate,
with the granules leaching amylose and absorbing water causing
them to swell and ultimately dissipate. When the solution is
subsequently cooled, the amylose and amylopectin re-associate,
turning the solution into a starch gel, with the gel strength
primarily determined by amylose content. These two stages
are referred to as gelatinization and retrogradation (Alcázar-
Alay and Meireles, 2015; Wang et al., 2015). Many types of
food processing, including cooking, can cause starch to undergo
gelatinization and retrogradation (Delcour et al., 2010) with co-
present substances becoming entrapped in the resulting starch gel
(Forssell, 2004).
The portion of starch that resists digestion in the small
intestine is termed “resistant starch” and varies between starch
source and type. In the case of the type of starch used in this
study (70% amylose starch from maize), the resistant starch
content has been reported as 46% on a w/w basis (McCleary
et al., 2002). Starch that is resistant due to its granular nature
is classified as type 2 resistant starch (RS2), whereas starch that
is resistant due to retrogradation is classified as type 3 resistant
starch (RS3) (Sajilata et al., 2006). Due to the capacity of the
resistant starch portion of a starch to resist digestion in the upper
GIT and subsequently be fermented by colonic bacteria, starch
based systems have been proposed for the colonic delivery of
drugs and bioactive materials; these systems frequently use ethyl
cellulose as a binder and are frequently produced through spray
coating (Milojevic et al., 1996; Dimantov et al., 2004; Desai, 2005;
Wilson and Basit, 2005; Freire et al., 2010; Pu et al., 2011; Situ
et al., 2014; Recife et al., 2017).
The aim of this study was to determine the effect, in vivo,
of orally consumed nisin on the lower GIT microbiota (as
determined by 16S rRNA HTS of fecal samples; Suzuki and
Nachman, 2016) when nisin was incorporated into two different
starch based matrices; a dough based on raw starch (RS2) and
a gel based on starch that had undergone gelatinization and
retrogradation (RS3). Additionally the potential of the starch
matrices themselves to impact on the microbiota was examined.
MATERIALS AND METHODS
Reagents
High amylose corn starch (HACS) was obtained from Sigma
Aldrich (S4180, Sigma Aldrich, Arklow, Ireland). Dextrose
equivalent 12 maltodextrin (DE12 MD) was obtained from
Roquette (Glucidex R© 12, Roquette, Corby, UK). All other
reagents were from Sigma Aldrich (Arklow, Ireland) unless
otherwise specified.
Preparation of Nisin
The nisin A preparation used in this study was Nisaplin R©
(DuPont, Beaminster, UK). This preparation was concentrated
by salting out as previously described (Gough et al., 2017a). This
resulted in a 57.7% nisin preparation which will subsequently be
referred to in the text as enriched nisin.
Preparation of Test Diet Pellets
Starch gels were prepared with and without nisin as follows.
Starch gels with nisin were composed of 1% (w/w) enriched nisin,
44% (w/w) HACS, and 55% (w/w) dilute HCl, with a final pH
of 3. Starch gels without nisin were composed of 45% (w/w)
HACS and 55% (w/w) dilute HCl, with a final pH of 3. The
suspensions were split into 10mL aliquots, heated at 115◦C for
15min and subsequently incubated at 4◦C for a minimum of 16 h
to ensure thorough retrogradation. Starch dough was prepared
with and without nisin as follows. The starch dough balls with
nisin comprised 1% (w/w) enriched nisin, 51.5% (w/w) HACS,
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22.5% DE12 MD, and 25% (w/w) dilute HCl. The starch dough
balls without nisin contained 52.5% (w/w) HACS, 22.5% DE12
MD, and 25% (w/w) dilute HCl. For the preparation of the nisin
containing starch dough balls, the dilute HCL and enriched nisin
(at pH 3) were heated at 115◦C for 15min and allowed cool to
room temperature before addition to the rest of the ingredients,
to ensure that the treatment of the nisin in the starch dough
was comparable with that of the nisin in the starch gel. All
the components of the starch dough balls were then mixed in
a laminar flow cabinet. Each starch dough ball was thoroughly
kneaded to achieve homogeneity and firmness. The starch dough
balls were stored at 4◦C until use.
Feeding Schedule and Sample Collection
This study was carried out in accordance with European
Directive 2010/63/EU. The protocol was approved by the
University College Cork Animal Experimentation Ethics
Committee (2011/005). Male C57BL/6JOlaHsd mice aged 3–4
weeks (Envigo, Alconbury, UK) were group housed (5 per
cage) and were maintained in a 12:12 h light-dark cycle. During
the initial 10 day acclimatization period, the mice were fed a
standard nutritionally complete low-fat rodent diet (D12450B,
Research Diets, New Brunswick, New Jersey, US); this diet is
henceforth referred to as the nutritionally complete (NC) diet.
Subsequently weight matched mice were assigned to receive the
following test diets: starch dough (SD), starch dough containing
nisin (SD-N), starch gel (SG), and starch gel containing nisin
(SG-N) (n= 10 per test diet).
An overview of the feeding schedule is shown in Table 2. The
feeding schedule involved initially switching the NC diets with
the test diets for 2 h per day for 3 days and this was gradually
increased to 8 h per day over the period of the trial as described
in Table 2.The test diets were introduced gradually to acclimatize
the animals to eating the starch based diets. The exposure to
the NC diets thus decreased from 22 to 16 h per day over the
period of the trial. The test diets were replaced every 4 days to
ensure the freshness of the diet pellets. As mice are nocturnal
animals and the cage room was on a 12:12 h light-dark cycle, the
food hoppers were switched to test diets at the beginning of the
dark cycle (18:00). The food hoppers were weighed throughout
the trial as described in Table 2 and additional food hoppers in
empty cages were used as controls to measure the impact of diet
pellet drying on diet pellet weight. The hoppers were loaded with
sufficient pellets of the test and NC diets to ensure that a sufficient
quantity of test/NC diet was provided to the mice for ad libitum
consumption at all times.
The mice were weighed and fecal pellets collected during the
course of the experiment as outlined in Table 2. At these time
points fecal pellets were obtained from each mouse and stored at
−80◦C individually for 16S RNA sequencing. For MALDI TOF
mass spectroscopy, HPLC and activity assays composite fecal
samples were obtained by pooling the fecal pellets by cage at
each time point. To limit contamination of the samples, the fecal
pellets were collected directly from the mice and not from the
bedding.
DNA Extraction, Amplification, and
Sequencing
DNA was extracted from fecal pellets using a QIAamp R©
Fast DNA Stool Kit (Qiagen, Crawley, UK) according to the
manufacturer’s instructions with somemodifications. To increase
DNA yield, after the addition of InhibitEX buffer, bead beating
(3min × 2) and an incubation at 95◦C for 5min, were
performed. The samples were quantified using a Qubit R© dsDNA
High Sensitivity Assay Kit (Fisher Scientific, Dublin, Ireland)
in conjunction with a Qubit R© 2.0 fluorometer (Invitrogen,
Paisley, UK). The initial amplification PCRs were performed as
outlined in the Illumina 16S Metagenomic Sequencing Library
Preparation Guide (Illumina, Saffron Walden, UK) with the
following alterations; 30 amplification cycles were used and the
amplification PCRs were each performed in a total volume of
60 µL which contained 25 ng DNA and 1 µL of each primer
at a 10µM concentration. The subsequent clean up using the
AMPure R© XP purification system (Labplan, Dublin, Ireland) was
scaled up appropriately to account for the greater volume. The
index PCRs and subsequent AMPure R© XP clean up were as
outlined in the Illumina protocol. The samples were quantified
using the Qubit R© procedure and the concentrations normalized
to 20 nM and pooled as per the Illumina protocol. The pooled
sample (100 µL) was purified using AMPure R© XP beads and
the sample eluted using 50 µL of a 10mM Tris solution. The
pooled sample was quantified using the Qubit R© procedure
and sample quality was determined using an Agilent 2100
Bioanalyzer (Agilent, Cork, Ireland). The pooled sample was
denatured and sequenced using a 500 cycle v2 kit on theMiSeq
TM
sequencing platform (Illumina, Saffron Walden, UK) following
protocols outlined by Illumina at the Teagasc Sequencing Centre,
Moorepark.
Bioinformatics Analysis
Sequences were filtered on the basis of quality (removal of
low quality nucleotides at the 3′ end) and length (removal
TABLE 2 | Feeding schedule and days of fecal pellet collection and mouse and food hopper weighing.
Day 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
Fecal pellet collection X X X X X
Mice weighed X X X X X X
Food hopper weighed X X X X X X X X X X X X X X X
Hours on test diet 2 2 2 4 4 4 4 4 6 6 6 8 8 8 8 n/a
Hours on nutritionally complete diet 22 22 22 20 20 20 20 20 18 18 18 16 16 16 16 n/a
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of sequences with <200 nt) with PRINSEQ (Schmieder and
Edwards, 2011) and joined using fastq-join (Aronesty, 2011). The
sequences were clustered with 97% identity level (calculated at
the operational taxonomic unit; OTUs) using closed-reference
USEARCH v7.0 algorithm (Edgar, 2010) against the Ribosomal
Database Project (Wang et al., 2007). Alpha and beta-diversity
was determined using QIIME (Caporaso et al., 2010). The results
of principal coordinates analysis (PCoA) of the beta-diversity
when it was calculated using distance matrices built from
unweighted UniFrac distances, were visualized using EMPeror
(Vázquez-Baeza et al., 2013).
Preparation of Fecal Pellets for Detection
of Nisin
To detect nisin in the fecal pellets, the nisin was extracted
from the pellets as described by Rea et al. (2014) with
minor modifications as follows: composite fecal samples were
suspended in 1mL of 0.1% TFA and 70% IPA, vortexed
thoroughly and allowed to stand at room temperature for 30min
and centrifuged for 5min at 16,000 × g and the supernatant
retained. The centrifugation step was repeated a further three
times with the supernatant retained each time. In order to bring
the IPA content of the samples to <7%, IPA was removed using a
Centrivap Console (Labconco, Kansas City, US) and the samples
were then restored to their original volumes using 0.1% TFA.
Reversed Phase—High Performance
Liquid Chromatography (RP-HPLC)
RP-HPLC was carried out on a Jupiter, 5µm, C18, 300 Å, 250
× 4.6mm column from Phenomenex (Macclesfield, UK) with an
acetonitrile (Thermo Fisher Scientific, Dublin, Ireland) gradient
as described previously (Gough et al., 2017a).
Matrix-Assisted Laser
Desorption/Ionization Time of Flight Mass
Spectroscopy (MALDI TOF MS)
The molecular mass of the HPLC fraction corresponding to the
nisin peak was determined using MALDI TOF MS using an
Axima TOF2 (Shimadzu Biotech, Kyoto, Japan) as previously
described (Field et al., 2012).
Activity Assay
Antibacterial activity was estimated by agar diffusion activity
assays (Ryan et al., 1996) in agar plates seeded with L. lactis
subsp. cremorisHP as described previously (Gough et al., 2017a).
Nisin was extracted from the fecal pellets as described above
and Tween R© 80 was added to a final concentration of 1% to
prevent nonspecific adsorption of the nisin. The samples were
dispensed into the wells of the seeded agar in 50 µL aliquots
and the plates incubated overnight at 30◦C. Antibacterial activity
resulted in zones of inhibition surrounding the wells. Nisin was
quantified based on a published method (Bernbom et al., 2006)
by plotting the area of the zone of inhibition against the log of
the nisin concentration of a serial dilution of Nisaplin R© that was
suspended in an equivalent solution to the samples (6% IPA, 0.1%
TFA, 1% Tween R© 80), to generate a linear standard curve.
Statistical Analysis
Data was tested for normality of distribution using the Shapiro–
Wilk test. For comparing two groups Student’s t-test or Mann–
Whitney U-test were used as appropriate and for comparison of
multiple groups one-way ANOVA or Kruskal–Wallis test were
used as appropriate, additionally analysis of beta diversity was
performed using the Adonis function in the R package Vegan
(Oksanen et al., 2015). Analysis of the bioinformatics data was
performed using the R statistical package (R Core Team, 2015)
and all other analysis was performed using the SigmaStat software
(Systat Software, San Jose, US). Results are expressed as mean ±
standard error.
RESULTS
Quantity of Diets Consumed and Effect on
Weight Gain
The cumulative consumption of the NC and test diets and
resultant body weight gain are shown in Figure 1. There were
no significant differences in body weight gain or in NC diet
consumption between diet groups over the trial period with three
exceptions, each of which occurred only at a single measurement
time point; the consumption of the NC partner diet for SD and
SG-N in the 6 h consumption period was significantly different
(p = 0.02, n = 6), the weight gain for the mice on the SG and
SG-N diets from days 4 to 7 of the trial was significantly different
(p = 0.02, n = 10) and the weight gain for the mice on the SD
and SG diets from days 11 to 15 of the trial was significantly
different (p = 0.0004, n = 10). The total consumption per
cage of the SD-N and SG-N test diets was 20.8 ± 2.5 and 6.5
± 2.0 g, respectively, and the daily consumption of these diets
were significantly different during the 6 h (p = 0.00007, n = 6)
and 8 h (p = 0.00003, n = 8) consumption period. The total
nisin consumption per cage over the course of the trial was 144
± 14 and 52 ± 11mg for the SD-N and SG-N diet groups,
respectively, and the daily consumption of the nisin portion
of those diets were also significantly different during the 6 h
(p = 0.0003, n = 6) and 8 h (p = 0.00002, n = 8) consumption
period. The average nisin consumption per day per cage during
the 8 h consumption period was 17 ± 1 and 6 ± 2mg for the
SD-N and SG-N diets groups, respectively. Therefore, there was
approximately a three-fold greater consumption of nisin by mice
on the SD-N diet compared to mice on the SG-N diet. For SD-
N compared to SD, SG-N compared to SG and SD compared to
SG there were no statistically significant differences during the
6 h (p = 0.134, 0.101, and 0.217, respectively, n = 6) and 8 h
(p = 0.507, 0.442, and 0.54, n = 8) consumption periods (days
9–15 of the trial).
Identification and Quantification of Intact
Nisin and Nisin Fragments in the Feces
The activity assays of the fecal pellets from mice consuming
SD, SD-N, SG, and SG-N diets (Figure 2A) showed antibacterial
activity in feces from mice that consumed the SD-N and SG-
N diets. MALDI TOF MS was performed on fecal pellets to
determine their intact nisin and nisin fragment composition
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FIGURE 1 | Consumption of each diet and the relationship between diets and weight gain. (A) Cumulative consumption of nutritionally complete (NC) partner diets for
each diet group, (B) cumulative consumption of test diets for each diet group, (C) cumulative weight gain for each diet group. Diet groups are defined by their test diet
as follows: blue circle - starch dough (SD), red square - starch dough containing nisin (SD-N), green triangle - starch gel (SG), black cross - starch gel containing nisin
(SG-N).
(Figures 2B,C). Their primary nisin components were then
determined by RP-HPLC in conjunction with MALDI TOF MS
(Figures 2D,E). For comparison purposes intact nisin was also
analyzed by RP-HPLC in conjunction with MALDI TOF MS
(Figures 2F,G).
MALDI TOF MS of the fecal pellets of mice on the SD-
N (Figure 2B) and SG-N diets (Figure 2C) showed masses that
correlated with intact nisin and nisin fragments 22–31 (i.e.,
corresponding to amino acids 22–31 of intact nisin) and 21–31;
these nisin fragments are the products of the digestion of nisin
and have predicted molecular masses of 1063.47 and 1195.44 Da,
respectively (Slootweg et al., 2013). Versions of nisin fragment
22–31 with a Na adduct ion (+22 Da) and a K adduct ion
(+38 Da) were also detected. Intact nisin, extracted from the
fecal pellets, was seen in its doubly charged form at 1676.46 and
1675.61 Da for the SD-N diet and for the SG-N, respectively.
RP-HPLC of the fecal pellets of mice on the SG-N diet
showed a single dominant peak (Figure 2D) that eluted at 41%
acetonitrile and MALDI TOF MS of this peak revealed it to be
nisin fragment 22–31 (Figure 2E). A similar result was obtained
for the fecal pellets of mice on the SD-N diet (result not
shown). Therefore, the primary nisin component of the feces was
fragment 22–31, as opposed to intact nisin.
Intact nisin normally elutes from a RP-HPLC at 36%
acetonitrile (Figure 2F) and subsequent MALDI TOF MS of
this elution peak shows both singly (3354.46 Da) and doubly
(1677.68 Da) charged intact nisin (Figure 2G). However, while
no intact nisin was detected by HPLC, antibacterial activity was
detected in the feces of those groups fed the SD-N and SG-N diets
(Figure 2A). This would suggest that the nisin concentration in
the fecal pellets was below the level of detection by HPLC.
Quantifying the intact nisin in the feces at the final time
point based on antibacterial activity showed significantly more
(p= 0.031, n= 3) nisin in the feces of the group fed SG-N (1.7±
0.2 ng/mg) compared to the groups fed SD-N (0.8 ± 0.1 ng/mg),
despite the fact that less nisin was consumed by the group fed the
SG-N diet, which would indicate that more intact nisin reached
the lower GIT in SG-N-fedmice. Therefore, at the final time point
(8 h test diet period), despite the significantly (p= 0.00002, n= 8)
greater nisin consumption of the mice on the SD-N diets, there
was significantly (p= 0.031, n= 3) greater nisin in the feces from
consumption of the SG-N diets.
HTS-Based Analysis of Microbiota
Following total metagenomic DNA extraction from the fecal
pellets from day 15, 16S rRNA gene amplicons (V3–V4 region)
were generated and sequenced using the Illumina MiSeqTM
platform. The mean number of sequence reads and alpha
diversity indices for each diet group are shown in Table 3. There
were no statistical differences in the alpha diversity indices:
Observed operational taxonomic units (unique operational
taxonomic units), Chao1 (richness), ACE (richness), Simpson
(richness and evenness), and Shannon (richness and evenness),
between the diet groups (Table 3). However, when the beta
diversity was calculated using distance matrices built from
unweighted UniFrac distances and the PCoA results visualized
using EMPeror (Vázquez-Baeza et al., 2013), the four treatment
groups formed distinct clusters based on diet (Figure 3), which
were significantly different (p= 0.001, n= 10).
Sequence analysis revealed that the microbiota were primarily
comprised of six phyla and that Bacteroidetes and Firmicutes
were the dominant phyla showing a relative abundance of 54–62
and 25–33%, respectively. There were no significant differences
between the relative abundance of Bacteroidetes and Firmicutes
across the diet groups (Figure 4), however there were significant
differences (p < 0.001, n = 10) in the relative abundance
between diet groups in the phyla Actinobacteria, Tenericutes, and
Verrucomicrobia (Figure 4).
A number of statistical differences were found at genus level
between the different dietary groups (Figure 5 and Table 4). The
mice fed the SG-N diet had significantly lower relative abundance
of the genera Allobaculum, Bifidobacterium, Lachnospiracea
incertae sedis, and Clostridium cluster XIVa and significantly
higher relative abundance of the genera Escherichia/Shigella,
Lactococcus, and Corynebacterium compared to the mice fed
the SG diet (p < 0.001, n = 10). These changes were
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FIGURE 2 | Analysis of fecal pellets of mice consuming starch dough (SD), starch dough containing nisin (SD-N), starch gel (SG), and starch gel containing nisin
(SG-N) diets. Activity assay of fecal pellets of mice consuming SD, SD-N, SG, and SG-N diets (A). Mass spectroscopy of fecal pellets from mice consuming SD-N
(B) and SG-N diets (C). RP-HPLC chromatogram of fecal pellets from mice consuming SG-N (D) and mass spectroscopy of the elution peak (E). RP-HPLC
chromatogram of intact nisin (F) and mass spectroscopy of the elution peak (G).
reflected at the corresponding family level. However, there
was also a significantly higher (p = 0.0005, n = 10) relative
abundance of the family Ruminococcaceae (Table 4) in mice
fed the SG-N diet that did not correspond to a significant
increase of any genus related to the Ruminococcaceae family.
This likely reflects the combined increases (not individually
statistically significant) in the proportions of the genera
Anaerotruncus and Hydrogenoanaerobacterium, i.e., members of
the Ruminococcaceae family, in mice that consumed the SG-
N diet. Relative to the SD diet, the SD-N diet significantly
(p < 0.001, n = 10) affected the relative abundance of only three
genera; i.e., Lactobacillus and Bifidobacterium, which were lower,
and Escherichia/Shigella, which were higher (Table 4).
There were also differences between the diet groups when
compared on the basis of starchmatrix. The relative abundance of
the generaAnaeroplasma, Bifidobacterium, andOdoribacter were
significantly (p < 0.001, n = 10) greater in the mice fed the SD
diet compared to the SG diet, whereas the relative abundance
of the genera Akkermansia, Lachnospiracea incertae sedis, and
Parabacteroides were all significantly (p < 0.001, n = 10) greater
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TABLE 3 | Mean sequence reads and alpha diversity indices for starch dough (SD), starch dough containing nisin (SD-N), starch gel (SG), and starch gel containing nisin
(SG-N) diet groups (mean ± standard error, n = 10).
SD SD-N SG SG-N
Sequence reads 43,465 (±7,276) 52,311 (±4,629) 39,848 (±3,909) 42,903 (±4,969)
Observed operational taxonomic units 267 (±19) 300 (±12) 246(±11) 296 (±22)
Chao1 277 (±18) 309 (±12) 254(±12) 303 (±22)
ACE 279 (±18) 310 (±12) 256(±11) 304 (±22)
Shannon 3.58 (±0.03) 3.58 (±0.05) 3.57(±0.04) 3.69 (±0.10)
Simpson 0.947 (±0.002) 0.941 (±0.005) 0.947(±0.003) 0.940 (±0.007)
Inverse simpson 19.1 (±0.8) 17.8 (±1.2) 19.4(±1.0) 18.7 (±2.2)
FIGURE 3 | Principal coordinates analysis PCoA of the unweighted UniFrac distances of the 168 sequencing data. The four diet groups are represented by colored
circles: blue—starch dough (SD), green—starch dough containing nisin (SD-N), red—starch gel (SG), brown—starch gel containing nisin (SG-N). The groups are
significantly different (p = 0.001, n = 10).
FIGURE 4 | Relative abundance at phylum level with respect to each diet. Diet groups are as follows: starch dough (SD), starch dough containing nisin (SD-N), starch
gel (SG), and starch gel containing nisin (SG-N) diet (n = 10).
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FIGURE 5 | Relative abundance at genus level with respect to each diet. Diet group are as follows: starch dough (SD), starch dough containing nisin (SD-N), starch
gel (SG), and starch gel containing nisin (SG-N) diet (n = 10).
in the mice fed the SG diet relative to the SD diet (Figure 5 and
Table 4). In addition, Clostridium cluster XIVb andDesulfovibrio
had greater relative abundance in the mice fed the SG and SG-N
diets compared to the mice fed the SD and SD-N diets (Table 4)
and this was significantly different (p < 0.001, n = 10) for the
SG-N diet group compared to the SD-N diet group.
DISCUSSION
The aim of this study was to determine if orally ingested nisin
could be delivered to the lower GIT in two different starch
matrices and subsequently impact on the lower GIT microbiota.
Additionally, it was examined whether the type of starch itself
could modulate the lower GIT microbiota.
To the authors’ knowledge (Table 1) the only study that
has examined the effect of orally ingested nisin on the rodent
microbiota is the study on rats by Bernbom et al. (2006), in which
the highest amount of nisin consumed was 174mg nisin per kg
body weight per day and, while nisin was detected in the feces,
no changes in the microbiota were detected which may be due
to the sensitivity of the molecular methods used in that study.
In this study it was hoped that using a 16s HTS approach and
similar levels of nisin as described by Bernbom et al. (2006),
it would be possible to determine the impact of nisin on the
microbiota. All test diets were increased at intervals over the
trial to acclimatize the mice to consuming starch and nisin. At
the 8 h consumption period the mice consumed 161 and 54mg
nisin per kg body weight per day for the SD-N and SG-N diets,
respectively. To limit the stress on the mice they were allowed
unrestricted access to a diet within a given consumption period,
however this approach limited a more precise matching of the
amount fed to the Bernbom et al. (2006) study.
Numerous studies have shown that nisin is susceptible to
digestion by the enzymes in the upper GIT and a previous study
by our group using the in vitro INFOGEST digestion model for
the human GIT, detected nisin fragments corresponding to the
N-terminus of nisin (amino acids 1–11, 1–12, 1–20, 1–21, 1–29,
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TABLE 4 | Bacterial taxa whose relative abundance was significantly different between diet groups.
SD SD-N SG SG-N
SIGNIFICANT AT GENUS LEVEL
Akkermansia 0.499 (±0.111)a 2.120 (±1.077) 11.943 (±2.369)a 15.879 (±4.789)
Allobaculum 4.764 (±0.827) 11.690 (±2.107)b 7.018 (±1.245)d 1.504 (±0.528)bd
Anaeroplasma 7.307 (±1.905)a 14.442 (±2.667)b 0.799 (±0.180)a 0.385 (±0.174)b
Bifidobacterium 10.317 (±0.902)ac 0.005 (±0.001)bc 4.894 (±0.602)ad 0.090 (±0.030)bd
Clostridium cluster XIVa 7.777 (±1.044) 6.731 (±0.577)b 8.003 (±1.261)d 1.685 (±0.646)bd
Clostridium cluster XIVb 0.289 (±0.095) 0.226 (±0.045)b 0.777 (±0.117) 0.831 (±0.145)b
Corynebacterium 0.007 (±0.002) 0.021 (±0.007) 0.007 (±0.003)d 0.091 (±0.018)d
Desulfovibrio 0.222 (±0.058) 0.119 (±0.031)b 0.350 (±0.076) 0.415 (±0.058)b
Escherichia/Shigella 0.009 (±0.005)c 3.860 (±1.971)c 0.011 (±0.002)d 3.771 (±1.795)d
Lachnospiraceae incertae sedis 1.248 (±0.375)a 0.126 (±0.091) 7.579 (±1.410)ad 0.336 (±0.281)d
Lactobacillus 3.536 (±0.470)c 0.643 (±0.330)c 1.378 (±0.351) 4.828 (±3.140)
Lactococcus 0.168 (±0.024) 0.533 (±0.080) 0.095 (±0.014)d 0.580 (±0.143)d
Odoribacter 18.711 (±2.515)a 21.817 (±1.322)b 1.164 (±0.186)a 6.058 (±2.205)b
Parabacteroides 0.996 (±0.160)a 0.835 (±0.108) 3.042 (±0.662)a 4.597 (±1.200)
NOT SIGNIFICANT AT GENUS LEVEL BUT SIGNIFICANT AT FAMILY LEVEL
Ruminococcaceae 2.285 (±0.468) 3.296 (±0.420) 2.157 (±0.273)d 7.759 (±0.684)d
Unclassified Ruminococcaceae 1.519 (±0.356) 2.228 (±0.259) 1.492 (±0.201)d 5.284 (±0.423)d
Diet groups are as follows: starch dough (SD), starch dough containing nisin (SD-N), starch gel (SG), and starch gel containing nisin (SG-N). The relative abundance of each bacterial
taxon is expressed as mean ± standard error. The same letter after a pair of values in a single row indicates these values are significantly different (p < 0.001, n = 10): (a) SD compared
to SG, (b) SD-N compared to SG-N, (c) SD compared to SD-N, and (d) SG compared to SG-N.
and 1–32) post digestion, while no intact nisin was detected
(Gough et al., 2017b). In this study, low levels of biologically
active nisin (ng/mg of feces) were detected in the feces of mice
fed SG-N and SD-N, but, in contrast to the in vitro study, the
primary nisin component of the feces was fragment 22–31, which
is not biologically active as the N-terminus is required for nisin
activity (Hsu et al., 2004). It is also notable that the fragments
produced by the in vivo digestion had a significant portion of
their C-terminal present whereas those produced by the in vitro
digestion had a significant portion of their N-terminal present.
These differences can most likely be attributed to species-related
differences in digestive enzymes.
More nisin was detected in the fecal samples of themice on the
SG-N diet despite them having consumed less nisin than those on
the SD-N diet; implying that more intact nisin reached the lower
GIT on the SG-N diet and that the starch gel may have afforded
some protection to the nisin from digestion in the upper GIT. To
the authors’ knowledge there are no reported studies of the in vivo
effect of nisin on the gut microbiota using HTS techniques.
The results of 16S rRNA compositional sequencing showed that
alpha diversity indices for all diet groups were comparable to
those seen in previous studies on fecal samples from C57BL/6J
mice on low-fat diets (Allen et al., 2015; Javurek et al., 2017).
Notably, however, beta diversity analysis showed that the murine
microbiotas clustered together on the basis of diet. With respect
to taxonomy, significant differences in the relative abundance
between diet groups were observed for the phyla Actinobacteria,
Tenericutes, and Verrucomicrobia (p < 0.001, n = 10). In each
case a single genus, i.e., Bifidobacterium, Anaeroplasma, and
Akkermansia, respectively, comprised themajority (>98%) of the
genera detected belonging to these phyla.
There were differences between the cumulative consumption
of SD compared to SG (Figure 1B), however as detailed above,
those differences were not statistically significant for the 6 and
8 h consumption periods (days 9–15 of the trial). Resistant starch
is known to effect satiety (Lockyer and Nugent, 2017). The
hormones glucagon-like peptide 1 (GLP-1) and peptide tyrosine-
tyrosine (PYY) which are involved in the regulation of satiety and
glycemic response (D’Alessio, 2008) have been demonstrated to
be elevated by resistant starch consumption in studies on mice
(Zhou et al., 2008). Although to the authors knowledge while
the relative ability of difference resistant starch types to effect
satiety has not been elucidated, it has been shown that different
types of resistant starch elicit significantly different glycemic
responses (Haub et al., 2010). Therefore, it may be possible that
the differences in consumption of the SD and SG are due to
differences in the effect of RS2 and RS3 on satiety, however this
was not investigated further in this study given our focus on the
effects of nisin on the gut microbiota.
There were also differences between the cumulative
consumption of SG-N compared to SG, and SD-N compared
to SD (Figure 1B), however as detailed above, those differences
were not statistically significant for the 6 and 8 h consumption
periods (days 9–15 of the trial). This reduction in consumption is
unlikely to be due to an effect of nisin on the microbiota as such
a change in the microbiota would also affect the consumption of
the NC diets and there were no statistically significant differences
between the consumption of their respective partner NC diets
throughout the trial (Figure 1A).While high protein diets have
been shown to increase satiety, the level of protein in the nisin
containing diets (∼0.58%) is unlikely to have had an effect
on satiety in this case (Batterham et al., 2006; Yu et al., 2009;
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Wiessing et al., 2015). However, it is possible that the palatability
of nisin may have contributed to the reduced consumption of the
nisin containing diets.
A limitation of this study is that the mice consumed different
quantities of each of the test diets (Figure 1B). While this
could have confounded the effect of nisin on the microbiota
of the diet groups when SD is compared to SD-N and SG is
compared to SG-N (Table 4), the changes in the microbiota,
nonetheless, are consistent with the specific effect of nisin on
these microorganisms. The difference in the amount of starch
consumed and resistant starch type could have confounded the
effects of the nisin. However, when comparing diets containing
dough and gel (Table 4), of the eight genera that showed a
significant difference (p < 0.001, n = 10) in relative abundance,
only two genera were also significantly different (p < 0.001,
n = 10) in relative abundance when SD-N was compared to SD
and SG-Nwas compared to SG. Additionally, of these two genera,
Lachnospiraceae incertae sedis was only significantly different
(p < 0.001, n = 10) in relative abundance in SG-N compared to
SG, while Bifidobacterium showed significantly lower (p < 0.001,
n = 10) relative abundance in both the SD-N compared to SD
and SG-N compared to SG. It has been reported previously
that Bifidobacterium are particularly sensitive to nisin relative
to other intestinal bacteria (Le Blay et al., 2007). Furthermore,
nisin primarily targets Gram positive bacteria. Interestingly
the genera that were significantly lower (p < 0.001, n = 10)
in relative abundance in SD-N compared to SD and SG-N
compared to SG (Table 4) were Gram positive or primarily
Gram positive (Clostridium cluster XIVa), whereas the genera
and family that significantly increased (p < 0.001, n = 10) in
relative abundance in SD-N compared to SD and SG-N compared
to SG (Table 4) were either Gram negative (Escherichia/Shigella),
contained Gram negative members (Ruminococcaceae) or may
have had nisin resistant mechanisms that are known to be present
in some strains (Lactococcus and Corynebacterium) (Brenner
et al., 2005; De Vos et al., 2009; Goodfellow et al., 2012; Zhou
et al., 2014; Draper et al., 2015; Gharsallaoui et al., 2016). Taking
these points together, we hypothesize that one reason for the
differences in relative abundance between SD-N compared to SD
and SG-N compared to SG is the presence or absence of nisin in
the test diets.
Starch based doughs have been proposed for use for the
oral delivery of drugs to laboratory rodents as a stress free
alternative to oral gavage (Corbett et al., 2012). We observed in
preliminary in vitro studies, that SD-N when placed in water
rapidly dissociated releasing the nisin, whereas SG-N did not
dissociate and nisin release was limited. Therefore, it is possible
that the nisin would be released earlier and more rapidly from
the SD-N than from the SG-N, which would in turn result in
more of the nisin being digested in the upper GIT by the digestive
enzymes secreted there and therefore impacting less on the
microbiota in the lower GIT than nisin incorporated into the SG-
N. While it is acknowledged that there are difficulties discerning
the effect of the rate of release of the starch matrices from the
effect of the level of consumption and resistant starch type, the
compositional sequencing provides some evidence that nisin was
released from the SD-N early in GIT transit and from the SG-N
late in GIT transit. The relative abundance of Lactobacillus, which
are primarily residents in the upper GIT that in turn transiently
populate the lower GIT (Denev, 2006;Walter, 2008), was reduced
in the SD-N fed group but were unaffected in the SG-N fed
group, which may point to an earlier release in the upper GIT
resulting in fewer lactobacilli reaching the colon. Additionally the
SG-N diet affected the relative proportion of more than three
times as many genera that are primarily resident in the lower
GIT than were affected by the SD-N diet (when comparing both
with their respective “starch only” controls); this indicates that
the SG-N delivered more nisin to the lower GIT than the SD-N.
Furthermore, despite there being approximately three-fold lower
consumption of nisin by the mice on the SG-N diet compared
to the mice on the SD-N diet, there was approximately twice as
much nisin detected in the feces of the mice that consumed the
SG-N diet compared to those that consumed the SD-N diet.
Bifidobacterium and Escherichia/Shigella were the only two
genera significantly (p < 0.001, n = 10) different in both the
SD-N and SG-N diet groups compared to the SD and SG
diet groups. Bifidobacteria have been demonstrated to attenuate
Escherichia/Shigella in several studies, including in mice (Gibson
and Wang, 1994; Shu and Gill, 2001; Cheikhyoussef et al.,
2007). It is possible that a nisin mediated reduction in the
relative abundance of bifidobacteria allowed Escherichia/Shigella
to increase in relative abundance; particularly as these were the
only two genera resident in the lower GIT that were significantly
different when the SD-N and SD diet groups were compared.
While it would be interesting to determine whether the
changes in the microbiota seen in this study could occur at
substantially lower levels of nisin consumption such as those
found in food, a dose response study would be required to
evaluate this. The current acceptable daily intake (ADI) is 1mg
nisin per kg body weight per day (Younes et al., 2017) while
typical levels added to foods range from 2.5 to 25 mg/kg (Delves-
Broughton, 2005).
Resistant starch is capable of modulating the microbiota in
the lower GIT and its effect depends on the type of resistant
starch (Bird et al., 2000; Martínez et al., 2010). Many of the genera
whose relative abundance was significantly different (p < 0.001,
n = 10) when compared on the basis of resistant starch
type including Akkermansia, Anaeroplasma, Bifidobacterium,
Lachnospiracea, Odoribacter, and Parabacteroides have positive
health associations (Leahy et al., 2005; Noor et al., 2010;
Kverka et al., 2011; Reeves et al., 2012; Vital et al., 2014; Zeng
et al., 2015; Gómez-Gallego et al., 2016). Of particular interest
was the alteration in the relative abundance of Akkermansia
which has been described as a “next generation probiotic”
(Cani and Van Hul, 2015) and is associated with numerous
health benefits including treating type 2 diabetes, reducing the
occurrence of autoimmune diseases and in weight management
(Gómez-Gallego et al., 2016). Akkermansia in the murine gut is
generally low (Schubert et al., 2015). Diets that include resistant
starch have been shown previously to increase the relative
abundance of Akkermansia (Tachon et al., 2013). There was
less SG (RS3) consumed than SD (RS2) over the course of the
study (Figure 1B), although as detailed above, this difference in
consumption was not significant during the 6 or 8 h consumption
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periods (days 9–15 of the trial), however the relative abundance
of Akkermansia was significantly (p = 0.0002, n = 10) greater
in mice fed the SG (RS3) than the SD (RS2) diet (12 and 0.5%
relative abundance, respectively). This may be attributable to
the type of starch, however confirmation of this would require
further investigation using NC diets incorporating the various
starch types.
Overall, while it may be possible to attribute the differences
in the microbiota between the diet groups to the effects of the
diet components, it is important to highlight that these may not
all be direct effects. The GIT microbiota is an interdependent
community and the effect of a diet component on members of
that network may promote other members that were not directly
affected by the diet component (Willing et al., 2011; Scott et al.,
2015).
Increased body weight gain due to nisin consumption has
been demonstrated in previous studies involving chickens and
rabbits (Table 1). However, in this study, no effect of nisin on
body weight was observed, regardless of the matrix used for
delivery. This is consistent with studies involving rats and quails
and the majority of studies involving mice (Table 1).
CONCLUSIONS
This study showed that by using a starch matrix, nisin can
be delivered to the lower GIT and will impact on the lower
GIT microbiota. All four diets altered the mouse microbiota
differently, with the differences between the two nisin containing
diets may be attributable to differences in how nisin was released
and protected by the two starch matrices, while the differences
between the starch matrices may be attributable to the type
of resistant starch (type 2 and type 3) favoring the abundance
of different bacterial taxa. It was particularly notable how
the relative abundance of the probiotic Akkermansia differed
between the two resistant starch diets however the difference
in consumption between starch diets makes comparisons more
difficult and this would need to be addressed in a further study.
Despite greater consumption of the SD-N diet, the SG-N diet
resulted in larger amounts of intact nisin in the feces and
appeared to affect a greater number of lower GIT bacterial taxa.
This highlights the importance of the matrix when studying
the activity of a bioactive peptide either as a food additive or
as a therapeutic for gastrointestinal pathogens. This study also
demonstrated, in an in vivo model, the usefulness of resistant
starch, particularly in a retrograded gel, for the colonic delivery
of a bioactive peptide. This system may be of use for other
heat stable peptides, including those with a narrower range of
antimicrobial activity.
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